Dydyk AM, Jain NK, Gupta M, Opioid Use D. 2024. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 31985959. https://www.ncbi.nlm.nih.gov/books/NBK553166/. Accessed: July 1, 2024.
Keyes KM, Rutherford C, Hamilton A, Barocas JA, Gelberg KH, Mueller PP, Feaster DJ, El-Bassel N, Cerdá M. What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size. Drug Alcohol Depend Rep. 2022;3:100052. https://doi.org/10.1016/j.dadr.2022.100052.
The Lancet Regional Health-Americas. Opioid crisis: addiction, overprescription, and insufficient primary prevention. Lancet Reg Health Am. 2023;23:100557. https://doi.org/10.1016/j.lana.2023.100557.
Florence C, Luo F, Rice K. The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017. Drug Alcohol Depend. 2021;218:108350. https://doi.org/10.1016/j.drugalcdep.2020.108350.
Jennings K. Economic Toll of Opioid Epidemic: $1.3 Trillion a Year. Forbes. https://www.forbes.com/sites/katiejennings/2022/02/04/economic-toll-of-opioid-epidemic-13-trillion-a-year/. Accessed: July 1, 2024.
Miron O, Barda N, Balicer R, Kor A, Lev-Ran S. Association of opioid use disorder with healthcare utilization and cost in a public health system. Addiction. 2022;117:2880–6. https://doi.org/10.1111/add.15963.
United States General Accounting Office (GOA). 2003. OxyContin Abuse and Diversion and Efforts to Address the Problem. GAO-04-110; Washington, DC. https://www.gao.gov/assets/gao-04-110.pdf. Accessed: July 1, 2024.
Nicholas R. (2019). Pharmaceutical opioids in Australia: A double-edged sword. National Centre for Education and Training on Addiction (NCETA), Flinders University, Adelaide. https://nceta.flinders.edu.au/application/files/3616/0156/0373/Pharmaceutical_opioids_in_Australia_A_double-edged_sword.pdf. Accessed: July 1, 2024.
Shapira B, Rosca P. Mountain or molehill? A scoping review of evidence on an opioid use problem in Israel. Drugs: Educ Prev Policy. 2021;29:595–603. https://doi.org/10.1080/09687637.2021.1922609.
Judd D, King CR, Galke C. The opioid epidemic: a review of the contributing factors, negative consequences, and best practices. Cureus. 2023;15:e41621. https://doi.org/10.7759/cureus.41621.
European Monitoring Centre for Drugs and Drug Addiction. (EMCDDA, 2024), European Drug Report 2024: Trends and Developments. https://www.emcdda.europa.eu/publications/european-drug-report/2024_en. Accessed: July 1, 2024.
Jones CM, Han B, Baldwin GT, Einstein EB, Compton WM. Use of medication for opioid use disorder among adults with past-year opioid use disorder in the US, 2021. JAMA Netw Open. 2023;6:e2327488. https://doi.org/10.1001/jamanetworkopen.2023.27488.
Shvartzman P, Freud T, Singer Y, Brill S, Sherf M, Battat E, Vardy D. Opioid use in an Israeli health maintenance organization: 2000–2006. Pain Med. 2009;10:702–7. https://doi.org/10.1111/j.1526-4637.2009.00621.x.
Ponizovsky AM, Marom E, Zeldin A, Cherny NI. Trends in opioid analgesics consumption, Israel, 2000–2008. Eur J Clin Pharmacol. 2011;67:165–8. https://doi.org/10.1007/s00228-010-0932-0.
Ponizovsky AM, Marom E, Weizman A, Schwartzberg E. Changes in consumption of opioid analgesics in Israel 2009 to 2016: an update focusing on oxycodone and fentanyl formulations. Pharmacoepidemiol Drug Saf. 2018;27:535–40. https://doi.org/10.1002/pds.4415.
Miron O, Zeltzer D, Shir T, Balicer RD, Einav L, Feldman BS. Rising opioid prescription fulfillment among non-cancer and non-elderly patients-Israel’s alarming example. Reg Anesth Pain Med. 2021;46:455–6. https://doi.org/10.1136/rapm-2020-101924.
Shapira B, Berkovitz R, Haklai Z, Goldberger N, Lipshitz I, Rosca P. Trends and correlated outcomes in population-level prescription opioid and transdermal fentanyl use in Israel. Isr J Health Policy Res. 2023;12:9. https://doi.org/10.1186/s13584-023-00558-9.
Dressler RL, Kaliner E, Cohen MJ. Trends in Israeli community-based opioid prescribing, 2010–2020, an observational study of the country’s largest HMO. Isr J Health Policy Res. 2023;12:34. https://doi.org/10.1186/s13584-023-00581-w.
Adler L, Cohen B, Shapiro Ben Daviv S, Liran O, Rahamim-Cohen D, Nakhleh A, Shahar A, Azuri J. Use of prescription opioids in Israel and socio-economic correlations between 2010 and 2020. Isr J Health Policy Res. 2024;13:12. https://doi.org/10.1186/s13584-024-00598-9.
Svendsen K, Borchgrevink P, Fredheim O, Hamunen K, Mellbye A, Dale O. Choosing the unit of measurement counts: the use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses. Palliat Med. 2011;25:725–32. https://doi.org/10.1177/0269216311398300.
Nielsen S, Gisev N, Bruno R, Hall W, Cohen M, Larance B, Campbell G, Shanahan M, Blyth F, Lintzeris N, Pearson S, Mattick R, Degenhardt L. Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment. Pharmacoepidemiol Drug Saf. 2017;26:587–91. https://doi.org/10.1002/pds.4168.
Menahem S, Freud T, Batat E, Shvartzman P. Opioid consumption by cancer patients in an Israeli health maintenance Organization from 2007–2018. Support Care Cancer. 2023;31:560. https://doi.org/10.1007/s00520-023-08027-4.
Fairley M, Humphreys K, Joyce VR, Bounthavong M, Trafton J, Combs A, Oliva EM, Goldhaber-Fiebert JD, Asch SM, Brandeau ML, Owens DK. Cost-effectiveness of treatments for opioid use disorder. JAMA Psychiatry. 2021;78:767–77. https://doi.org/10.1001/jamapsychiatry.2021.0247.
Marom A, Levy I, Rosca P. Changes and trends in medication-assisted treatment in Israel. Isr J Health Policy Res. 2023;12:1. https://doi.org/10.1186/s13584-022-00551-8.
Hébert AH, Hill AL. Impact of opioid overdoses on US life expectancy and years of life lost, by demographic group and stimulant co-involvement: a mortality data analysis from 2019 to 2022. Lancet Reg Health Am. 2024;36:100813. https://doi.org/10.1016/j.lana.2024.100813.
Feingold D, Goldberger N, Haklai Z, Lev-Ran S. Fatal overdoses of opioids in Israel 2005–2014. Eur Addict Res. 2017;23:276–83. https://doi.org/10.1159/000485033.
Rosca P, Spivak P, Goldman K, Austin O. (2020). Summary of the Activity of the Department for the Treatment of Substance Abuse for Year 2019 [Hebrew]. https://www.health.gov.il/UnitsOffice/HD/MHealth/mental/addictions/Documents/mtl-addictions-2019.pdf. Accessed: July 1, 2024.
Slavova S, Delcher C, Buchanich JM, Bunn TL, Goldberger BA, Costich JF. Methodological complexities in quantifying rates of fatal opioid-related overdose. Curr Epidemiol Rep. 2019;6:263–74. https://doi.org/10.1007/s40471-019-00201-9.
Cohen MJ, Dressler RL, Kaliner E. Receipt of prescription opioid medication is associated with increased mortality in an Israeli population. Isr J Health Policy Res. 2024;13:17. https://doi.org/10.1186/s13584-024-00606-y.
Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. MMWR Recomm Rep. 2022;71(No. RR-3):1–95. https://doi.org/10.15585/mmwr.rr7103a1
Jalali MS, Botticelli M, Hwang RC, Koh HK, McHugh RK. The opioid crisis: a contextual, social-ecological framework. Health Res Policy Syst. 2020;18:87. https://doi.org/10.1186/s12961-020-00596-8.
Spencer MR, Warner M, Cisewski JA, Miniño A, Dodds D, Perera J, Ahmad FB. Estimates of drug overdose deaths involving fentanyl, methamphetamine, cocaine, heroin, and oxycodone: United States, 2021. Vital Statistics Rapid Release; no 27. Hyattsville, MD: National Center for Health Statistics. May 2023. https://doi.org/10.15620/cdc:125504
Jalal H, Burke DS. Exponential growth of drug overdose poisoning and opportunities for intervention. Addiction. 2022;117:1200–2. https://doi.org/10.1111/add.15841.
Meinhofer A. Prescription drug monitoring programs: the role of asymmetric information on drug availability and abuse. Am J Health Econ. 2018;4:504–26. https://doi.org/10.1162/ajhe_a_00101.
Khazen M, Kamin-Friedman S. Overlooking the obvious: the importance of communicating safety and risks of opioids-the Israeli context. Front Pharmacol. 2022;15:1356968. https://doi.org/10.3389/fphar.2024.1356968.
Humphreys K, Shover CL, Andrews CM, Bohnert ASB, Brandeau ML, Caulkins JP, Chen JH, Cuéllar MF, Hurd YL, Juurlink DN, Koh HK, Krebs EE, Lembke A, Mackey SC, Larrimore Ouellette L, Suffoletto B, Timko C. Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission. Lancet. 2022;399:555–604. https://doi.org/10.1016/S0140-6736(21)02252-2.
Rubin R, Suran M. Supervised consumption sites—a tool for reducing risk of overdose deaths and infectious diseases in people who use illicit drugs. JAMA. 2022;327:1532–4. https://doi.org/10.1001/jama.2022.4017.
Miron O, Wolff-Sagy Y, Levin M, Lubich E, Lewinski J, Shpunt M, Abu Ahmad W, Borochov I, Netzer D, Lavie G. Fentanyl initiation rate following the requirement for specialist approval. medRxiv 2024.03.13.24304188; https://doi.org/10.1101/2024.03.13.24304188
Samet JH, Friedmann P, Saitz R. Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives. Arch Intern Med. 2001;161:85–91. https://doi.org/10.1001/archinte.161.1.85.
Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J, Screening. Brief intervention, and Referral to Treatment (SBIRT): toward a Public Health Approach to the management of substance abuse. Substance Abuse. 2007;28:7–30. https://doi.org/10.1300/J465v28n03_03.
Friedlander A, Tzur Bitan D, Lichtenberg P. The Soteria model: implementing an alternative to acute psychiatric hospitalization in Israel. Psychosis. 2022;14:99–108. https://doi.org/10.1080/17522439.2022.2057578.
Davidovitch N, Kranzler Y, Miron O. Are We Nearing an Opioid Epidemic in Israel? Taub Center for Social Policy Studies in Israel. 2023. https://www.taubcenter.org.il/wp-content/uploads/2023/03/Opioids-2023-ENG.pdf. Accessed: July 1, 2024.
Levi-Belz Y, Groweiss Y, Blank C, Neria Y. PTSD, depression, and anxiety after the October 7, 2023 attack in Israel: a nationwide prospective study. EClinicalMedicine. 2024;68:102418. https://doi.org/10.1016/j.eclinm.2023.102418.
Feingold D, Neria Y, Bitan DT. PTSD, distress and substance use in the aftermath of October 7th,2023 terror attacks in Southern Israel. J Psychiatr Res, 174:153–8 https://doi.org/10.1016/j.jpsychires.2024.04.022
Times of Israel. Israel sees sharp rise in addiction amid ongoing Gaza war. 2024. https://www.timesofisrael.com/israel-sees-sharp-rise-in-addiction-amid-ongoing-gaza-war/. Accessed: September 24, 2024.
Doctors Only. Effects of War: A spike in anti-anxiety and narcotic painkillers. 2024. [Hebrew]. https://doctorsonly.co.il/2024/09/326663/. Accessed: September 24, 2024.
Powell D. Educational attainment and US drug overdose deaths. JAMA Health Forum. 2023;4:e233274. https://doi.org/10.1001/jamahealthforum.2023.3274.
van Draanen J, Tsang C, Mitra S, Karamouzian M, Richardson L. Socioeconomic marginalization and opioid-related overdose: a systematic review. Drug Alcohol Depend. 2020;214:108127. https://doi.org/10.1016/j.drugalcdep.2020.108127.
Blanco C, Wiley TRA, Lloyd JJ, Lopez MF, Volkow ND. America’s opioid crisis: the need for an integrated public health approach. Transl Psychiatry. 2020;10:167. https://doi.org/10.1038/s41398-020-0847-1.
Truong TQ, Gandhi D, Rosenthal J et al. Tackling the Opioid Crisis Requires a Whole-of-Government, Society-Wide Approach. Center for American Progress. 2023. https://www.americanprogress.org/article/tackling-the-opioid-crisis-requires-a-whole-of-government-society-wide-approach/. Accessed: July 1, 2024.
Add Comment